2026 approvals, clinical data, and licensing deals are advancing subcutaneous biologics, reducing patient burden, and reshaping biopharma drug strategy.
|Articles|January 1, 2002
- Pharmaceutical Technology-01-02-2002
- Volume 26
- Issue 1
Novel Acrylate Adhesives for Transdermal Drug Delivery
Author(s)Adam S. Cantor, PhD, David J. Wirtanen
The authors discuss the solubility and adhesive performances of adhesives that incorporate monomers such as hydroxyethyl acrylate or pyrrolidonoethyl acrylate.
Advertisement
Articles in this issue
over 24 years ago
What Does Pharmacy Automation Mean for Packaging?over 24 years ago
Optimal Tablet Press Operation: Machine versus Granulationover 24 years ago
Manufacturers Face Shifting Priorities in the New Yearover 24 years ago
Investigation of Out-of-Specification Resultsover 24 years ago
Reaping the Benefits of E-Procurementover 24 years ago
Outsourcing OutlookAdvertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Can AI Agents Satisfy CGMP Documentation Requirements?
2
PharmTech Weekly Roundup—September 18, 2026
3
Introducing the "PharmTech AI Pulse Check" Expert Video Series
4
Two Audit Case Studies Reveal the Cost of Incomplete Corrective Actions
5